SI2857019T1 - Postopek zdravljenja multiple skleroze - Google Patents

Postopek zdravljenja multiple skleroze

Info

Publication number
SI2857019T1
SI2857019T1 SI201331768T SI201331768T SI2857019T1 SI 2857019 T1 SI2857019 T1 SI 2857019T1 SI 201331768 T SI201331768 T SI 201331768T SI 201331768 T SI201331768 T SI 201331768T SI 2857019 T1 SI2857019 T1 SI 2857019T1
Authority
SI
Slovenia
Prior art keywords
multiple sclerosis
treating multiple
treating
sclerosis
Prior art date
Application number
SI201331768T
Other languages
English (en)
Slovenian (sl)
Inventor
Frederic Sedel
Original Assignee
Assistance Publique, Hopitaux De Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique, Hopitaux De Paris filed Critical Assistance Publique, Hopitaux De Paris
Publication of SI2857019T1 publication Critical patent/SI2857019T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI201331768T 2012-07-26 2013-04-29 Postopek zdravljenja multiple skleroze SI2857019T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1257254A FR2993780B1 (fr) 2012-07-26 2012-07-26 Methode de traitement de la sclerose en plaque
US13/644,615 US8835487B2 (en) 2012-07-26 2012-10-04 Method of treating multiple sclerosis
EP14194213.6A EP2857019B1 (en) 2012-07-26 2013-04-29 Method of treating multiple sclerosis

Publications (1)

Publication Number Publication Date
SI2857019T1 true SI2857019T1 (sl) 2020-10-30

Family

ID=47294963

Family Applications (2)

Application Number Title Priority Date Filing Date
SI201330023T SI2729143T1 (sl) 2012-07-26 2013-04-29 Uporaba biotina za zdravljenje multiple skleroze
SI201331768T SI2857019T1 (sl) 2012-07-26 2013-04-29 Postopek zdravljenja multiple skleroze

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI201330023T SI2729143T1 (sl) 2012-07-26 2013-04-29 Uporaba biotina za zdravljenje multiple skleroze

Country Status (25)

Country Link
US (5) US8835487B2 (enExample)
EP (2) EP2857019B1 (enExample)
JP (1) JP6208235B2 (enExample)
KR (1) KR101967502B1 (enExample)
CN (2) CN104602689A (enExample)
AU (1) AU2013295370B2 (enExample)
BR (1) BR112015001562A2 (enExample)
CA (1) CA2879434C (enExample)
CY (1) CY1116304T1 (enExample)
DK (2) DK2857019T3 (enExample)
EA (1) EA030478B1 (enExample)
ES (3) ES2532364T3 (enExample)
FR (1) FR2993780B1 (enExample)
HK (1) HK1207583A1 (enExample)
HR (1) HRP20150260T1 (enExample)
HU (1) HUE024558T2 (enExample)
IL (1) IL236790A (enExample)
LT (1) LT2857019T (enExample)
ME (1) ME02060B (enExample)
PL (1) PL2729143T3 (enExample)
PT (2) PT2729143E (enExample)
RS (1) RS53893B1 (enExample)
SI (2) SI2729143T1 (enExample)
SM (1) SMT201500057B (enExample)
WO (1) WO2014016003A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2958166B1 (fr) * 2010-04-06 2012-07-13 Assist Publ Hopitaux De Paris Compositions pharmaceutiques fortement dosees en biotine
FR2993780B1 (fr) 2012-07-26 2015-02-13 Assist Publ Hopitaux De Paris Methode de traitement de la sclerose en plaque
WO2014177286A1 (en) 2013-04-29 2014-11-06 Assistance Publique - Hopitaux De Paris Biotin for use in treating x-linked adrenoleukodystrophy
US10344172B2 (en) * 2015-02-13 2019-07-09 Unimatec Co., Ltd. Fluorine-containing copolymer and surface-modifying agent comprising the same as active ingredient
EP3072513A1 (en) * 2015-03-26 2016-09-28 Medday Biotin for treating Amyotrophic lateral sclerosis
US20170135969A1 (en) 2015-11-12 2017-05-18 Jds Therapeutics, Llc Topical arginine-silicate-inositol for wound healing
RU2638803C2 (ru) * 2016-06-09 2017-12-15 Общество С Ограниченной Ответственностью "Валента-Интеллект" Таблетки биотина с замедленным высвобождением и способ их получения
WO2017086835A1 (ru) * 2015-11-17 2017-05-26 Общество С Ограниченной Ответственностью "Валента-Интеллект" Фармацевтическая композиция, обладающая терапевтическим эффектом в отношении демиелинизирующих заболеваний (варианты)
RU2611415C1 (ru) * 2015-11-17 2017-02-21 Общество С Ограниченной Ответственностью "Валента - Интеллект" ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ ТЕРАПЕВТИЧЕСКИМ ЭФФЕКТОМ В ОТНОШЕНИИ ДЕМИЕЛИНИЗИРУЮЩИХ ЗАБОЛЕВАНИЙ (Варианты)
EP3275439A1 (en) 2016-07-29 2018-01-31 Medday Pharmaceuticals Method for treating hepatic encephalopathy
MX2019002468A (es) * 2016-09-01 2019-09-18 Jds Therapeutics Llc Composiciones de biotinato de magnesio y metodos de uso.
RU2639488C1 (ru) * 2017-04-06 2017-12-21 Общество С Ограниченной Ответственностью "Валента - Интеллект" Фармацевтическая композиция, содержащая биотин, и способ ее получения
US20200155510A1 (en) * 2018-11-13 2020-05-21 Jds Therapeutics, Llc Treatment of autoimmune disorders, such as relapsing remitting multiple sclerosis and clinically isolated syndrome with biotin compositions
CN112076310A (zh) * 2019-06-14 2020-12-15 苏州融析生物科技有限公司 一种治疗多发性硬化的药物组合物及其制备
GB2613672A (en) 2019-12-16 2023-06-14 Nutrition 21 Llc Methods of production of aginine-silicate complexes
WO2021137257A1 (en) 2020-01-01 2021-07-08 Celagenex Research (India) Pvt. Ltd. Synergistic nutritional compositions for enhancing atp efficiency

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3609165A (en) 1968-07-19 1971-09-28 Research Corp 1,3-diazabicyclo {8 3.1.0{9 {0 hex-3-enes
JPH0995448A (ja) 1995-09-29 1997-04-08 Calpis Food Ind Co Ltd:The 血中ビオチン濃度の増加方法およびビオチン含有飲食品
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
US5789401A (en) 1997-08-08 1998-08-04 Nutrition 21 High-dose chromium/biotin treatment of type II diabetes
US6664039B1 (en) 1998-10-14 2003-12-16 California Institute Of Technology Methods and compositions for modulating neurodegeneration
UA73492C2 (en) * 1999-01-19 2005-08-15 Aromatic heterocyclic compounds as antiinflammatory agents
DE19903241A1 (de) 1999-01-28 2000-08-03 Merck Patent Gmbh Galenische Formulierung
US20050256178A1 (en) 2002-08-23 2005-11-17 Eggersdorfer Manfred L Novel nutraceutical compositions comprising boitin
US7709028B2 (en) 2002-09-30 2010-05-04 Daiichi Pharmaceutical Co., Ltd. Particulate product comprising pantethine
DE10341240A1 (de) * 2003-09-08 2005-04-07 Aventis Pharma Deutschland Gmbh Substituierte Thienoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP1706146B1 (en) * 2003-12-31 2013-08-21 K-Pax Pharmaceuticals, Inc. Nutrient compositions and use thereof for enhanced effectiveness of the immune system
IL162288A0 (en) * 2004-06-01 2005-11-20 Future Products Man S A Compositions and methods for treating neurodegenerative disorders
BG66011B1 (bg) * 2005-05-25 2010-10-29 Райна Щонова Състав от растителен произход
MX2012007365A (es) 2009-12-23 2012-08-15 Lupin Ltd Composiciones farmaceuticas de liberacion lenta de iloperidona.
FR2993780B1 (fr) 2012-07-26 2015-02-13 Assist Publ Hopitaux De Paris Methode de traitement de la sclerose en plaque
FR2958166B1 (fr) * 2010-04-06 2012-07-13 Assist Publ Hopitaux De Paris Compositions pharmaceutiques fortement dosees en biotine

Also Published As

Publication number Publication date
EP2857019A1 (en) 2015-04-08
CN104602689A (zh) 2015-05-06
US8835487B2 (en) 2014-09-16
DK2729143T3 (en) 2015-03-23
CN109908140A (zh) 2019-06-21
US9351961B2 (en) 2016-05-31
ME02060B (me) 2015-05-20
PT2857019T (pt) 2020-07-24
RS53893B1 (sr) 2015-08-31
JP6208235B2 (ja) 2017-10-04
SMT201500057B (it) 2015-05-05
EA030478B1 (ru) 2018-08-31
CA2879434C (en) 2019-04-23
AU2013295370A1 (en) 2015-02-19
KR20150042799A (ko) 2015-04-21
PT2729143E (pt) 2015-03-16
FR2993780A1 (fr) 2014-01-31
HK1207583A1 (en) 2016-02-05
PL2729143T3 (pl) 2015-05-29
BR112015001562A2 (pt) 2017-07-04
WO2014016003A1 (en) 2014-01-30
DK2857019T3 (da) 2020-08-17
AU2013295370B2 (en) 2017-03-02
EP2729143B1 (en) 2014-12-31
ES2811074T3 (es) 2021-03-10
ES2626079T3 (es) 2017-07-21
EP2857019B1 (en) 2020-05-27
EP2729143A1 (en) 2014-05-14
US20190117626A1 (en) 2019-04-25
CY1116304T1 (el) 2017-02-08
LT2857019T (lt) 2020-09-10
HRP20150260T1 (hr) 2015-05-08
US20140348920A1 (en) 2014-11-27
US20190117625A1 (en) 2019-04-25
EA201590270A1 (ru) 2015-11-30
KR101967502B1 (ko) 2019-04-09
HUE024558T2 (hu) 2016-02-29
US20140030331A1 (en) 2014-01-30
US20160324830A1 (en) 2016-11-10
FR2993780B1 (fr) 2015-02-13
JP2015522630A (ja) 2015-08-06
IL236790A (en) 2017-09-28
CA2879434A1 (en) 2014-01-30
SI2729143T1 (sl) 2015-05-29
US10201528B2 (en) 2019-02-12
ES2532364T3 (es) 2015-03-26

Similar Documents

Publication Publication Date Title
LT2857019T (lt) Išsėtinės sklerozės gydymo būdas
IL237791A0 (en) A method for treating cancer
GB201110095D0 (en) Method of treatment
EP2773754A4 (en) Methods of Treatment
SG11201503893RA (en) Method of treating cancer
ZA201500152B (en) Methods of treating arthritis
ZA201408353B (en) Method of treating hair
ZA201408342B (en) Method of treating hair
EP2879688A4 (en) METHODS OF TREATING ATHEROSCLEROSIS
EP2895206A4 (en) METHOD FOR TREATING CARCINOMA
IL260115A (en) Methods for treating fibrosis (Leifat)
ZA201408343B (en) Method of treating hair
EP2758780A4 (en) METHOD OF TREATING MULTIPLE SCLEROSIS
ZA201406567B (en) Method for treatment of labor arrest
GB201220155D0 (en) Method of manufacture
GB201215942D0 (en) Method of treatent
ZA201503833B (en) Method of hemoglobin-f determination
EP2791324A4 (en) PROCESSING METHOD
GB201221032D0 (en) Method of treatment
GB201207894D0 (en) Method of treatment
GB201321600D0 (en) Method of cleaning
GB201103044D0 (en) Method of treatment
GB201109509D0 (en) Method of treatment
GB201109266D0 (en) Method of treatment
GB201111530D0 (en) Method of treatment